Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sofinnova
Biotech
Gene therapy biotech secures $150M for eye disease candidates
Atsena has raised $150 million to advance its gene therapy designed to reverse or prevent blindness.
Gabrielle Masson
Apr 2, 2025 7:30am
Sofinnova closes €165M European biotech acceleration fund
Mar 18, 2025 4:01am
Sofinnova's €1.2B to fuel up to 60 life sciences companies
Mar 4, 2025 4:56am
Why biotechs can benefit from the 'rational' IPO environment
Jan 24, 2025 10:30am
2 eye disease biotechs merge, set sights on FDA approval
Dec 12, 2024 11:05am
BioAge eyes $180M from IPO, private placement for obesity trials
Sep 25, 2024 7:55am
